title: [Chronic myeloid leukemia--case report].
authors.affiliation: Krankenhaus München-Harlaching, VI. Medizinische Abteilung, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Hentrich
authors.forename: O J
authors.initials: OJ
authors.lastname: Stoetzer
authors.forename: C
authors.initials: C
authors.lastname: Salat
authors.forename: G
authors.initials: G
authors.lastname: Ledderose
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides; D016026:Bone Marrow Transplantation; D003561:Cytarabine / Q000008:administration & dosage; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage; D000068877:Imatinib Mesylate; D016898:Interferon-alpha / Q000008:administration & dosage; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000628:therapy*; D017710:Lymphocyte Transfusion; D008297:Male; D010879:Piperazines / Q000008:administration & dosage; D011379:Prognosis; D011743:Pyrimidines / Q000008:administration & dosage; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D016898:Interferon-alpha; D010879:Piperazines; D011743:Pyrimidines; D003561:Cytarabine; D000068877:Imatinib Mesylate; D006918:Hydroxyurea